Starting thrombolytic therapy for patients with acute myocardial infarction in accident and emergency department: From implementation to evaluation

Chinese Medical Journal

Volumn 111, Issue 4, 1998, Pages 291-294

  Chan, Wai Kwong ^a   Lam, Koon Ngai ^a   Lau, Fei Lung ^a   Tang, Ho Ming ^a  

^a UNITED CHRISTIAN HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ARTICLE; DRUG EFFICACY; EMERGENCY TREATMENT; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; ST SEGMENT;

EMERGENCIES; EMERGENCY TREATMENT; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 0031948738     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Gruppo Italiano per lo Studio della Streptochinasi nell' Infarto Miocardico (GISSI). Effectiveness, of intravenous thromboyltic treatment in acute myocardial infarction. Lancet 1986; 1:397.
2. National Heart Attack Alert Program Coordinating Committee, 60 Minutes to Treatment Working Group. Emergency Department: rapid indentification and treatment of patients with acute myocardial infarction. Ann Emerg Med 1994; 23:311.
3. More R, Moore K. Delay times in the administration of the thrombolytic therapx: the Brighton experience. Int J Cardiol 1995; 49 (Suppl):S39.
4. Verheugt FW, Funke K. Emergency room infusion of intravenous streptokinese in acute myocardial infarction: feasibility, safety and haemodynamic consequence. Ann Heart J 1989; 117:1018.
5. Pell ACH, Miller HC. Effect of "fast track" admission for acute myocardial infusion on delay to thrombolysis. BMJ 1992; 304:83.
6. MacCallum AG, Stafford PJ. Reduction in hospital time to thrombolytic therapy by audit of policy guildlines. Eur Heart J 1990; 11 (Suppl F):48.
7. Chan WK, Chiu CS, Yue CS, et al. Can the door-to-needle of giving thrombolytic therapy in acute myocardial infarction patients be shortened? (abstract). J HK Coll Cardiol 1994; 2(1):62.
8. Craeme Porter. Thrombolysis in acute myocardial infarction: reducing in-hospital treatment delay. N Zealand Med J 1995; 28:253.
9. Bristish heart foundation group Guildlines for the early management of patient with myocardial infarction. BMJ 1994; 308:767.
10. Recommandations for eusursing early thrombolytic therapy for acute myocardial infarction. Can Med Assoc 1996; 154(4) :483.
11. Maynard C, Weaver WD. Factor influencing the time to administration of thrombolytic therapy with RTPA. Am J Cardiol 1995; 76:548.
12. ISIS Collaboration group. Randomised trial of intravenous Streptokdnease, oral aspirin both or neither among 17187 cases of su- pected acute myocardial infarction. Lancet 1988; ii:349.
13. Chan WK, Chiu A, Yue CS. Prevalence of various complications of thrombolytic therapy in patients with acute myocardial infarction: experience in a local regional hospital. J HK Coll Cardiol 1996; 4 (2):77.
14. Zoltie N. Changing standards for thrombolysis in accident and emergency department. J AE Med 1995; 12:132.
15. Rustige JM, Burczyk U. Effect of a media campaign on delay times in suspected acute myocardial infarction - the Ludwigshafen pro-ject. Eur Heart J 1990; 11 (Suppl):171.
16. Weaver WD, Cerqueina M. Prehospital-initiated vs hospital-initiated thrombolytic therapy. JAMA 1993; 270:1211.
17. The European Myocardial Infarction Project Group. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med 1993; 329:383.